Your browser is no longer supported. Please, upgrade your browser.
ANGO AngioDynamics, Inc. daily Stock Chart
AngioDynamics, Inc.
Index- P/E84.69 EPS (ttm)0.28 Insider Own0.10% Shs Outstand36.65M Perf Week4.31%
Market Cap859.81M Forward P/E24.88 EPS next Y0.94 Insider Trans-5.02% Shs Float36.22M Perf Month12.84%
Income10.40M PEG4.03 EPS next Q0.22 Inst Own- Short Float4.23% Perf Quarter13.83%
Sales349.00M P/S2.46 EPS this Y75.70% Inst Trans0.81% Short Ratio7.93 Perf Half Y8.96%
Book/sh14.66 P/B1.60 EPS next Y10.94% ROA2.50% Target Price21.00 Perf Year43.93%
Cash/sh1.21 P/C19.45 EPS next 5Y21.00% ROE3.30% 52W Range15.26 - 24.49 Perf YTD16.54%
Dividend- P/FCF29.05 EPS past 5Y54.60% ROI1.90% 52W High-4.21% Beta0.75
Dividend %- Quick Ratio1.90 Sales past 5Y0.10% Gross Margin53.40% 52W Low53.74% ATR0.48
Employees1145 Current Ratio2.90 Sales Q/Q5.50% Oper. Margin3.90% RSI (14)76.38 Volatility2.10% 2.04%
OptionableYes Debt/Eq0.26 EPS Q/Q742.90% Profit Margin5.10% Rel Volume0.58 Prev Close23.15
ShortableYes LT Debt/Eq0.25 EarningsJan 04 BMO Payout0.00% Avg Volume193.02K Price23.46
Recom3.00 SMA208.65% SMA5012.05% SMA20010.17% Volume112,658 Change1.34%
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-05-18Downgrade Craig Hallum Buy → Hold
Apr-07-17Reiterated Cantor Fitzgerald Overweight $20 → $21
Mar-30-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-08-17Initiated Barclays Equal Weight $17
Nov-04-16Initiated Cantor Fitzgerald Buy
Apr-08-16Resumed Piper Jaffray Neutral
Jan-08-16Reiterated Canaccord Genuity Buy $17.50 → $14.50
Nov-10-15Downgrade Raymond James Outperform → Mkt Perform
Jul-24-15Initiated KeyBanc Capital Mkts Overweight
Jun-19-14Upgrade Canaccord Genuity Hold → Buy $16.25 → $20
Oct-09-12Reiterated Canaccord Genuity Hold $14 → $13.50
Jun-25-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
Jul-15-11Upgrade Stifel Nicolaus Hold → Buy $16.50
Jul-15-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
Jun-14-11Downgrade Wedbush Neutral → Underperform $14 → $12
Sep-08-10Reiterated Wedbush Neutral $17.50 → $14
Mar-04-10Initiated Wedbush Morgan Neutral $17.50
Sep-04-09Reiterated Caris & Company Above Average $13 → $15
Jul-17-09Reiterated Caris & Company Above Average $15 → $13
Feb-18-19 08:30AM  Cryolife (CRY) Earnings Miss, Revenues Top Estimates in Q4 Zacks
Feb-15-19 07:36AM  Quidel (QDEL) Q4 Earnings and Revenues Surpass Estimates Zacks
Feb-14-19 01:54PM  Quest Diagnostics (DGX) Q4 Earnings in Line, Margins Down Zacks
08:48AM  Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines Zacks
07:26AM  DaVita (DVA) Q4 Earnings Beat and Revenues Miss Estimates Zacks
Feb-13-19 08:14AM  Medidata (MDSO) Q4 Earnings Beat, Revenues Miss Estimates Zacks
Feb-12-19 09:09AM  Bruker (BRKR) Q4 Earnings In Line, Margin Growth Strong Zacks
08:37AM  STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates Zacks
Feb-11-19 09:40AM  IRADIMED (IRMD) Q4 Earnings Surpass Estimates, Margins Up Zacks
Feb-08-19 01:53PM  Phirbo (PAHC) Q2 Earnings Lag Estimates, Operating Margin Up Zacks
09:48AM  Omnicell (OMCL) Q4 Earnings Beat Estimates, Revenues Miss Zacks
Feb-07-19 10:20AM  LabCorp's (LH) Q4 Earnings and Revenues Surpass Estimates Zacks
09:27AM  Cardinal Health (CAH) Beats on Q2 Earnings, Ups FY19 View Zacks
Feb-06-19 05:07PM  Haemonetics (HAE) Earnings Top, Revenues Lag Estimates in Q3 Zacks
04:04PM  Boston Scientific (BSX) Beats on Q4 Earnings, Margins Dip Zacks
09:07AM  Myriad Genetics (MYGN) Q2 Earnings & Revenues Miss Estimates Zacks
08:45AM  Cerner (CERN) Q4 Earnings Meet Estimates, Revenues Miss Zacks
08:11AM  Luminex (LMNX) Q4 Earnings Miss, 2019 Guidance Lacks Luster Zacks
Feb-05-19 09:26AM  QIAGEN's (QGEN) Q4 Earnings In Line, Revenues Miss Mark Zacks
09:25AM  Becton, Dickinson (BDX) Q1 Earnings In Line With Estimates Zacks
Feb-04-19 08:33AM  Omnicell Solid on Geographic Expansion Amid Stiff Competition Zacks
Feb-03-19 09:30AM  AngioDynamics (ANGO) Up 8.7% Since Last Earnings Report: Can It Continue? Zacks
Feb-01-19 02:19PM  IDEXX (IDXX) Q4 Earnings Top Estimates, Raises '19 EPS View Zacks
10:13AM  PerkinElmer (PKI) Q4 Earnings Beat, Diagnostics Grows Y/Y Zacks
10:11AM  McKesson (MCK) Beats on Q3 Earnings, Gains From Solid View Zacks
09:55AM  Cardiovascular Systems (CSII) Q2 Earnings Top, Revenues Meet Zacks
09:22AM  Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Revenues Top Zacks
08:24AM  Edwards Lifesciences (EW) Q4 Earnings In Line, Revenues Top Zacks
07:08AM  ABIOMED (ABMD) Q3 Earnings Beat, Impella Maintains Momentum Zacks
Jan-31-19 12:05PM  Hologic's (HOLX) Q1 Earnings Beat Estimates, Guidance Raised Zacks
11:56AM  Surmodics (SRDX) Q1 Earnings & Revenues Beat, Guidance Solid Zacks
11:50AM  AmerisourceBergen (ABC) Beats on Q1 Earnings, Trims EPS View Zacks
11:42AM  Baxter's (BAX) Earnings, Revenues Beat Estimates in Q4 Zacks
Jan-30-19 09:50AM  Thermo Fisher (TMO) Beats on Earnings and Revenues in Q4 Zacks
09:32AM  Align Technology (ALGN) Beats on Earnings and Revenues in Q4 Zacks
09:02AM  Varian Strong on Global Expansion and Proton Therapy Arm Zacks
07:48AM  Stryker (SYK) Q4 Earnings Beat, International Revenues Surge Zacks
07:35AM  New Research Coverage Highlights Heron Therapeutics, IDACORP, Star Bulk Carriers, AngioDynamics, Marinus Pharmaceuticals, and Advaxis Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Jan-28-19 07:14AM  Hill-Rom's (HRC) Earnings and Revenues Top Estimates in Q1 Zacks
Jan-25-19 01:30PM  Estimating The Fair Value Of AngioDynamics, Inc. (NASDAQ:ANGO) Simply Wall St.
08:05AM  Intuitive Surgical (ISRG) Earnings Miss, Revenues Beat in Q4 Zacks
Jan-23-19 09:09AM  Accuray's (ARAY) Q2 Loss Narrows, Radixact Demand Shoots Up Zacks
08:05AM  CONMED (CNMD) Q4 Earnings Match Estimates, Revenues Beat Zacks
Jan-18-19 08:01AM  Here's Why Investors Should Hold AngioDynamics (ANGO) Now Zacks
Jan-14-19 10:03PM  Edited Transcript of ANGO earnings conference call or presentation 4-Jan-19 1:00pm GMT Thomson Reuters StreetEvents
Jan-07-19 08:14PM  AngioDynamics (ANGO) Q2 2019 Earnings Conference Call Transcript Motley Fool
09:35AM  AngioDynamics (ANGO) Q2 Earnings Beat on Gains From NanoKnife Zacks
07:43AM  Oncology business propels AngioDynamics to $91.5 million second quarter American City Business Journals
Jan-04-19 08:25AM  AngioDynamics (ANGO) Beats Q2 Earnings and Revenue Estimates Zacks +10.76%
07:18AM  AngioDynamics: Fiscal 2Q Earnings Snapshot Associated Press
07:00AM  AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results Business Wire
Dec-28-18 10:30AM  AngioDynamics (ANGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Dec-20-18 04:01PM  AngioDynamics to Present at the J.P. Morgan Healthcare Conference Business Wire
Dec-19-18 02:59PM  What Does AngioDynamics, Inc.s (NASDAQ:ANGO) P/E Ratio Tell You? Simply Wall St.
Dec-10-18 04:01PM  AngioDynamics to Report Fiscal 2019 Second Quarter Financial Results on January 4, 2019 Business Wire
Nov-13-18 02:54PM  Can AngioDynamics Inc (NASDAQ:ANGO) Improve Its Returns? Simply Wall St.
Oct-27-18 09:30AM  AngioDynamics (ANGO) Down 6.9% Since Last Earnings Report: Can It Rebound? Zacks
Oct-16-18 08:40AM  Consolidated Research: 2018 Summary Expectations for Mimecast, Shiloh Industries, Adverum Biotechnologies, AngioDynamics, Kimball Electronics, and Changyou Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-02-18 03:53PM  What does AngioDynamics Incs (NASDAQ:ANGO) Balance Sheet Tell Us About Its Future? Simply Wall St.
Oct-01-18 09:31AM  AngioDynamics (ANGO) Q1 Earnings Miss, '19 Sales View Up Zacks
Sep-28-18 01:11AM  Edited Transcript of ANGO earnings conference call or presentation 27-Sep-18 12:00pm GMT Thomson Reuters StreetEvents
Sep-27-18 08:25AM  AngioDynamics (ANGO) Lags Q1 Earnings Estimates Zacks -10.85%
07:21AM  AngioDynamics: Fiscal 1Q Earnings Snapshot Associated Press
07:00AM  AngioDynamics Reports Fiscal 2019 First Quarter Financial Results Business Wire
Sep-20-18 10:30AM  AngioDynamics (ANGO) Q1 Earnings Preview: What to Watch Ahead of the Release Zacks
07:56AM  What's in Store for AngioDynamics (ANGO) in Q1 Earnings? Zacks
Sep-19-18 04:01PM  AngioDynamics to Present at the Cantor Global Healthcare Conference Business Wire
08:44AM  Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now Zacks
Sep-14-18 02:34PM  AngioDynamics (ANGO) to Acquire RadiaDyne, Boost Oncology Zacks
08:16AM  AngioDynamics expands oncology business with acquisition of Houston co. American City Business Journals
Sep-13-18 04:01PM  AngioDynamics to Report Fiscal 2019 First Quarter Financial Results on September 27, 2018 Business Wire
07:00AM  AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio Business Wire
Sep-07-18 07:45AM  New Strong Sell Stocks for September 7th Zacks
Sep-02-18 10:12AM  How Should You Think About AngioDynamics Incs (NASDAQ:ANGO) Risks? Simply Wall St.
Aug-23-18 04:01PM  AngioDynamics to Present at Two Investor Conferences in September Business Wire
08:40AM  New Strong Sell Stocks for August 23rd Zacks
Aug-21-18 06:44AM  New Strong Sell Stocks for August 21st Zacks
Aug-17-18 07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within Okta, Great Lakes Dredge & Dock, MDC Partners, Colfax, Heritage-Crystal Clean, and AngioDynamics New Research Emphasizes Economic Growth GlobeNewswire
Aug-16-18 09:22AM  AngioDynamics' (ANGO) BioSentry Buyout to Boost Oncology Zacks
Aug-15-18 07:00AM  AngioDynamics Provides Updates on Oncology and Vascular Access Businesses Business Wire
Aug-10-18 10:06AM  Why Is AngioDynamics (ANGO) Up 5.02% Since Its Last Earnings Report? Zacks
Jul-30-18 09:05AM  Align, AngioDynamics and Caterpillar highlighted as Zacks Bull and Bear of the Day Zacks
07:00AM  Bear of the Day: AngioDynamics (ANGO) Zacks
Jul-19-18 10:37AM  Medical device company settles US case over false claims Associated Press
10:36AM  Medical device company settles US case over false claims Associated Press
Jul-18-18 05:26PM  AngioDynamics to pay $12.5 mln over false claims allegations -U.S. Justice Dept Reuters
07:00AM  Free Post Earnings Research Report: AngioDynamics' Revenues Improved 1.6%; Adjusted EPS Advanced 5.3% ACCESSWIRE
Jul-17-18 08:13AM  AngioDynamics (ANGO) Q4 Performance Dull, Competition Rife Zacks
Jul-12-18 08:46AM  AngioDynamics (ANGO) Misses Q4 Earnings & Revenue Estimates Zacks +8.18%
02:52AM  Edited Transcript of ANGO earnings conference call or presentation 11-Jul-18 12:00pm GMT Thomson Reuters StreetEvents
Jul-11-18 08:37AM  AngioDynamics (ANGO) Misses Q4 Earnings and Revenue Estimates Zacks -16.08%
07:12AM  AngioDynamics: Fiscal 4Q Earnings Snapshot Associated Press
07:00AM  AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results Business Wire
06:00AM  AngioDynamics, Inc. to Host Earnings Call ACCESSWIRE
Jul-10-18 02:33PM  Earnings Preview For AngioDynamics Benzinga
Jul-02-18 08:03AM  What's in Store for AngioDynamics (ANGO) in Q4 Earnings? Zacks
Jun-24-18 09:23AM  Estimating The Intrinsic Value Of AngioDynamics Inc (NASDAQ:ANGO) Simply Wall St.
Jun-21-18 04:01PM  AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018 Business Wire
May-29-18 08:15AM  Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-30-18 01:45AM  Why Is AngioDynamics (ANGO) Up 13.9% Since Its Last Earnings Report? Zacks
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. It also offers thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; and Asclera injection for treating uncomplicated spider and reticular veins of the lower extremities. Further, it provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation system; and radiofrequency ablation products for ablating solid cancerous or benign tumors. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greiner MichaelEVP and CFONov 07Sale21.531,93941,74720,731Nov 08 04:06 PM
Trowbridge Stephen ASVP and General CounselJul 12Option Exercise0.003,556040,110Aug 22 07:05 PM
GOLD JEFFREYDirectorJul 06Option Exercise13.537,00094,71070,906Jul 10 06:44 PM
JOHNSON WESLEYDirectorJun 22Option Exercise13.5314,000189,42060,974Jun 25 04:20 PM
Meteny Dennis SDirectorJun 21Option Exercise13.5314,000189,42083,127Jun 25 04:30 PM
DONNELLY HOWARD WDirectorJun 21Option Exercise10.686,65071,02265,353Jun 25 04:26 PM
GOLD JEFFREYDirectorJun 21Option Exercise13.537,00094,71068,134Jun 25 04:23 PM